熱門資訊> 正文
美敦力糖尿病部门MiniMed申请IPO
2025-12-20 05:30
- Medtronic plc (MDT) announced that its diabetes business, to operate as MiniMed, has filed a Form S-1 registration statement with the SEC for a proposed initial public offering.
- The separation is expected to be completed through capital markets transactions, with a preferred path of an IPO followed by a split-off.
- MiniMed plans to list its common stock on the Nasdaq Global Select Market under the ticker symbol "MMED".
- The number of shares to be offered and the IPO price range have not yet been determined.
More on Medtronic plc
- Medtronic: This Dividend Aristocrat Is Just Getting Started
- Medtronic plc (MDT) Q2 2026 Earnings Call Transcript
- Medtronic plc 2026 Q2 - Results - Earnings Call Presentation
- FDA making use of real-world evidence in device applications easier
- Insider trades: Coca-Cola, Ford among notable names this week
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。